Progressive publishes new research
Forecasts up after 'pay-as-you-go' acquisitionWe have raised our FY2023E and FY2024E PBT estimates for Scotland's only quoted housebuilder by 5% and 10%, respectively, following its £46m acquisition of the housebuilding business of Mactaggart & Mickel Group. The deal is structured with payments phased over five years in line with homes sold, so we are not changing our net debt estimates. Springfield also reiterated guidance for FY2022E, with improved net debt. |
Subscribe to Progressive's research, which is freely available to every type of investor, and be kept informed about our regular programme of investor engagement.
About Progressive:
Progressive is an equity research and investor engagement company. FCA authorised and regulated, the firm has a 15-strong team of highly experienced analysts. We provide Institutional grade research and connect companies with investors across every sector of the market.
www.progressive-research.com
Broad coverage
| Analyst calibre
| |||
across 12 sectors | ||||
| ||||
Business Services | Oil & Gas | 15 | with average | 20 |
Financials | Property | experience of | ||
Healthcare | Retail |
| ||
Industrials | Technology | 30+ |
| techMARK |
Investment Trusts | Telecoms | industry based | Extel | |
Mining | Utilities | awards | StarMine |
For further information please contact:
Keith Hodgskiss
+44 (0) 20 7781 5315
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.